Johnson & Johnson Accounts Payable 2010-2025 | JNJ

Johnson & Johnson accounts payable for the quarter ending June 30, 2025 were $9.464B, a 6.96% increase year-over-year.

  • Johnson & Johnson accounts payable for 2024 were $10.311B, a 7.05% increase from 2023.
  • Johnson & Johnson accounts payable for 2023 were $9.632B, a 2.6% decline from 2022.
  • Johnson & Johnson accounts payable for 2022 were $9.889B, a 10.55% decline from 2021.

Johnson & Johnson Accounts Payable 2010-2025 | JNJ

  • Johnson & Johnson accounts payable for 2024 were $10.311B, a 7.05% increase from 2023.
  • Johnson & Johnson accounts payable for 2023 were $9.632B, a 2.6% decline from 2022.
  • Johnson & Johnson accounts payable for 2022 were $9.889B, a 10.55% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$693.4B
AbbVie (ABBV)$371.7B
Novartis AG (NVS)$267.3B
Roche Holding AG (RHHBY)$259.4B
Novo Nordisk (NVO)$252.1B
Merck (MRK)$210.1B
Pfizer (PFE)$140.8B
Sanofi (SNY)$121.5B
Bayer (BAYRY)$32.3B
Innoviva (INVA)$1.3B